Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Tumor origin and growth pattern at diagnosis and surgical hypothalamic damage predict obesity in pediatric craniopharyngioma.

Park SW, Jung HW, Lee YA, Shin CH, Yang SW, Cheon JE, Kim IO, Phi JH, Kim SK, Wang KC.

J Neurooncol. 2013 Jul;113(3):417-24. doi: 10.1007/s11060-013-1128-0. Epub 2013 Apr 12.

2.

Craniopharyngioma and hypothalamic obesity in children.

Vinchon M, Weill J, Delestret I, Dhellemmes P.

Childs Nerv Syst. 2009 Mar;25(3):347-52. doi: 10.1007/s00381-008-0754-x. Epub 2008 Dec 5.

PMID:
19057910
3.

Magnetic resonance imaging-graded hypothalamic compression in surgically treated adult craniopharyngiomas determining postoperative obesity.

Van Gompel JJ, Nippoldt TB, Higgins DM, Meyer FB.

Neurosurg Focus. 2010 Apr;28(4):E3. doi: 10.3171/2010.1.FOCUS09303.

PMID:
20367360
4.

Obesity after childhood craniopharyngioma--German multicenter study on pre-operative risk factors and quality of life.

Müller HL, Bueb K, Bartels U, Roth C, Harz K, Graf N, Korinthenberg R, Bettendorf M, Kühl J, Gutjahr P, Sörensen N, Calaminus G.

Klin Padiatr. 2001 Jul-Aug;213(4):244-9.

PMID:
11528558
5.

Weight gain in craniopharyngioma--a model for hypothalamic obesity.

Ahmet A, Blaser S, Stephens D, Guger S, Rutkas JT, Hamilton J.

J Pediatr Endocrinol Metab. 2006 Feb;19(2):121-7.

PMID:
16562584
6.

Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma.

Müller HL, Emser A, Faldum A, Bruhnken G, Etavard-Gorris N, Gebhardt U, Oeverink R, Kolb R, Sörensen N.

J Clin Endocrinol Metab. 2004 Jul;89(7):3298-305.

PMID:
15240606
7.

Childhood craniopharyngioma: greater hypothalamic involvement before surgery is associated with higher homeostasis model insulin resistance index.

Trivin C, Busiah K, Mahlaoui N, Recasens C, Souberbielle JC, Zerah M, Sainte-Rose C, Brauner R.

BMC Pediatr. 2009 Apr 2;9:24. doi: 10.1186/1471-2431-9-24.

8.

Functional capacity, obesity and hypothalamic involvement: cross-sectional study on 212 patients with childhood craniopharyngioma.

Müller HL, Faldum A, Etavard-Gorris N, Gebhardt U, Oeverink R, Kolb R, Sörensen N.

Klin Padiatr. 2003 Nov-Dec;215(6):310-4.

PMID:
14677094
9.

[Childhood craniopharyngioma with hypothalamic obesity - no long-term weight reduction due to rehabilitation programs].

Sterkenburg AS, Hoffmann A, Gebhardt U, Waldeck E, Springer S, Müller HL.

Klin Padiatr. 2014 Nov;226(6-7):344-50. doi: 10.1055/s-0034-1387747. Epub 2014 Nov 28. German.

PMID:
25431867
10.

Influence of tumor location on the presentation and evolution of craniopharyngiomas.

Meuric S, Brauner R, Trivin C, Souberbielle JC, Zerah M, Sainte-Rose C.

J Neurosurg. 2005 Nov;103(5 Suppl):421-6.

PMID:
16302613
11.

Childhood craniopharyngioma: hypothalamus-sparing surgery decreases the risk of obesity.

Elowe-Gruau E, Beltrand J, Brauner R, Pinto G, Samara-Boustani D, Thalassinos C, Busiah K, Laborde K, Boddaert N, Zerah M, Alapetite C, Grill J, Touraine P, Sainte-Rose C, Polak M, Puget S.

J Clin Endocrinol Metab. 2013 Jun;98(6):2376-82. doi: 10.1210/jc.2012-3928. Epub 2013 Apr 30.

PMID:
23633208
12.

Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement.

Puget S, Garnett M, Wray A, Grill J, Habrand JL, Bodaert N, Zerah M, Bezerra M, Renier D, Pierre-Kahn A, Sainte-Rose C.

J Neurosurg. 2007 Jan;106(1 Suppl):3-12. Review.

PMID:
17233305
13.

Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma: results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow-up.

Müller HL, Gebhardt U, Teske C, Faldum A, Zwiener I, Warmuth-Metz M, Pietsch T, Pohl F, Sörensen N, Calaminus G; Study Committee of KRANIOPHARYNGEOM 2000..

Eur J Endocrinol. 2011 Jul;165(1):17-24. doi: 10.1530/EJE-11-0158. Epub 2011 Apr 13.

14.

Obesity in childhood craniopharyngioma: relation to post-operative hypothalamic damage shown by magnetic resonance imaging.

de Vile CJ, Grant DB, Hayward RD, Kendall BE, Neville BG, Stanhope R.

J Clin Endocrinol Metab. 1996 Jul;81(7):2734-7.

PMID:
8675604
15.

Perioperative dexamethasone treatment in childhood craniopharyngioma--influence on short-term and long-term weight gain.

Müller HL, Heinrich M, Bueb K, Etavard-Gorris N, Gebhardt U, Kolb R, Sörensen N.

Exp Clin Endocrinol Diabetes. 2003 Sep;111(6):330-4.

PMID:
14520598
16.

Childhood craniopharyngioma - changes of treatment strategies in the trials KRANIOPHARYNGEOM 2000/2007.

Hoffmann A, Warmth-Metz M, Gebhardt U, Pietsch T, Pohl F, Kortmann RD, Calaminus G, Müller HL.

Klin Padiatr. 2014 May;226(3):161-8. doi: 10.1055/s-0034-1368785. Epub 2014 May 12.

PMID:
24819386
17.

Prognosis and sequela in patients with childhood craniopharyngioma -- results of HIT-ENDO and update on KRANIOPHARYNGEOM 2000.

Müller HL, Gebhardt U, Etavard-Gorris N, Korenke E, Warmuth-Metz M, Kolb R, Sörensen N, Calaminus G.

Klin Padiatr. 2004 Nov-Dec;216(6):343-8.

PMID:
15565549
18.

Endocrine and neuroanatomic features associated with weight gain and obesity in adult patients with hypothalamic damage.

Daousi C, Dunn AJ, Foy PM, MacFarlane IA, Pinkney JH.

Am J Med. 2005 Jan;118(1):45-50.

PMID:
15639209
19.

Melatonin treatment in obese patients with childhood craniopharyngioma and increased daytime sleepiness.

Müller HL, Handwerker G, Gebhardt U, Faldum A, Emser A, Kolb R, Sörensen N.

Cancer Causes Control. 2006 May;17(4):583-9.

PMID:
16596314
20.

Magnetic resonance imaging as predictor of functional outcome in craniopharyngiomas.

Mortini P, Gagliardi F, Bailo M, Spina A, Parlangeli A, Falini A, Losa M.

Endocrine. 2016 Jan;51(1):148-62. doi: 10.1007/s12020-015-0683-x. Epub 2015 Jul 16.

PMID:
26179178

Supplemental Content

Support Center